FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894955366> ?p ?o ?g. }

• W2894955366 endingPage "2505" @default.
• W2894955366 startingPage "2495" @default.
• W2894955366 abstract "Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) affect >200 000 individuals yearly with a 40% mortality rate. Although platelets are implicated in the progression of ALI/ARDS, their exact role remains undefined. Triggering receptor expressed in myeloid cells (TREM)-like transcript 1 (TLT-1) is found on platelets, binds fibrinogen, and mediates clot formation. We hypothesized that platelets use TLT-1 to manage the progression of ALI/ARDS. Here we retrospectively measure plasma levels of soluble TLT-1 (sTLT-1) from the ARDS Network clinical trial and show that patients whose sTLT-1 levels were >1200 pg/mL had nearly twice the mortality risk as those with <1200 pg/mL (P < .001). After correcting for confounding factors such as creatinine levels, Acute Physiology And Chronic Health Evaluation III scores, age, platelet counts, and ventilation volume, sTLT-1 remains significant, suggesting that sTLT-1 is an independent prognostic factor (P < .0001). These data point to a role for TLT-1 during the progression of ALI/ARDS. We use a murine lipopolysaccharide-induced ALI model and demonstrate increased alveolar bleeding, aberrant neutrophil transmigration and accumulation associated with decreased fibrinogen deposition, and increased pulmonary tissue damage in the absence of TLT-1. The loss of TLT-1 resulted in an increased proportion of platelet-neutrophil conjugates (43.73 ± 24.75% vs 8.92 ± 2.4% in wild-type mice), which correlated with increased neutrophil death. Infusion of sTLT-1 restores normal fibrinogen deposition and reduces pulmonary hemorrhage by 40% (P ≤ .001) and tissue damage by 25% (P ≤ .001) in vivo. Our findings suggest that TLT-1 uses fibrinogen to govern the transition between inflammation and hemostasis and facilitate controlled leukocyte transmigration during the progression of ARDS." @default.
• W2894955366 created "2018-10-12" @default.
• W2894955366 creator A5007461026 @default.
• W2894955366 creator A5015492156 @default.
• W2894955366 creator A5017612230 @default.
• W2894955366 creator A5030734396 @default.
• W2894955366 creator A5036045556 @default.
• W2894955366 creator A5038407943 @default.
• W2894955366 creator A5038643808 @default.
• W2894955366 creator A5041858848 @default.
• W2894955366 creator A5043536058 @default.
• W2894955366 creator A5044753697 @default.
• W2894955366 creator A5048870956 @default.
• W2894955366 creator A5060003523 @default.
• W2894955366 creator A5063554695 @default.
• W2894955366 creator A5066897615 @default.
• W2894955366 creator A5068488599 @default.
• W2894955366 creator A5080326695 @default.
• W2894955366 creator A5082675564 @default.
• W2894955366 creator A5089160868 @default.
• W2894955366 creator A5089922398 @default.
• W2894955366 date "2018-12-06" @default.
• W2894955366 modified "2023-10-18" @default.
• W2894955366 title "Platelet-derived TLT-1 is a prognostic indicator in ALI/ARDS and prevents tissue damage in the lungs in a mouse model" @default.
• W2894955366 cites W1600560134 @default.
• W2894955366 cites W1967199549 @default.
• W2894955366 cites W1969653234 @default.
• W2894955366 cites W1971381181 @default.
• W2894955366 cites W1999060840 @default.
• W2894955366 cites W2000647523 @default.
• W2894955366 cites W2001315007 @default.
• W2894955366 cites W2004796256 @default.
• W2894955366 cites W2009148773 @default.
• W2894955366 cites W2015332717 @default.
• W2894955366 cites W2020893836 @default.
• W2894955366 cites W2021181719 @default.
• W2894955366 cites W2029677015 @default.
• W2894955366 cites W2049271604 @default.
• W2894955366 cites W2053740009 @default.
• W2894955366 cites W2100806851 @default.
• W2894955366 cites W2107130244 @default.
• W2894955366 cites W2119301960 @default.
• W2894955366 cites W2127785805 @default.
• W2894955366 cites W2131069275 @default.
• W2894955366 cites W2132882829 @default.
• W2894955366 cites W2145094503 @default.
• W2894955366 cites W2146981926 @default.
• W2894955366 cites W2158369873 @default.
• W2894955366 cites W2159763561 @default.
• W2894955366 cites W2160053026 @default.
• W2894955366 cites W2190171834 @default.
• W2894955366 cites W2280425429 @default.
• W2894955366 cites W2528987226 @default.
• W2894955366 cites W2597070792 @default.
• W2894955366 cites W2620241325 @default.
• W2894955366 cites W2758334268 @default.
• W2894955366 cites W2800809688 @default.
• W2894955366 cites W2804761147 @default.
• W2894955366 cites W36951521 @default.
• W2894955366 cites W4229746629 @default.
• W2894955366 cites W4236162659 @default.
• W2894955366 cites W4248053214 @default.
• W2894955366 cites W64676342 @default.
• W2894955366 doi "https://doi.org/10.1182/blood-2018-03-841593" @default.
• W2894955366 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6284217" @default.
• W2894955366 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30282800" @default.
• W2894955366 hasPublicationYear "2018" @default.
• W2894955366 type Work @default.
• W2894955366 sameAs 2894955366 @default.
• W2894955366 citedByCount "30" @default.
• W2894955366 countsByYear W28949553662018 @default.
• W2894955366 countsByYear W28949553662019 @default.
• W2894955366 countsByYear W28949553662020 @default.
• W2894955366 countsByYear W28949553662021 @default.
• W2894955366 countsByYear W28949553662022 @default.
• W2894955366 countsByYear W28949553662023 @default.
• W2894955366 crossrefType "journal-article" @default.
• W2894955366 hasAuthorship W2894955366A5007461026 @default.
• W2894955366 hasAuthorship W2894955366A5015492156 @default.
• W2894955366 hasAuthorship W2894955366A5017612230 @default.
• W2894955366 hasAuthorship W2894955366A5030734396 @default.
• W2894955366 hasAuthorship W2894955366A5036045556 @default.
• W2894955366 hasAuthorship W2894955366A5038407943 @default.
• W2894955366 hasAuthorship W2894955366A5038643808 @default.
• W2894955366 hasAuthorship W2894955366A5041858848 @default.
• W2894955366 hasAuthorship W2894955366A5043536058 @default.
• W2894955366 hasAuthorship W2894955366A5044753697 @default.
• W2894955366 hasAuthorship W2894955366A5048870956 @default.
• W2894955366 hasAuthorship W2894955366A5060003523 @default.
• W2894955366 hasAuthorship W2894955366A5063554695 @default.
• W2894955366 hasAuthorship W2894955366A5066897615 @default.
• W2894955366 hasAuthorship W2894955366A5068488599 @default.
• W2894955366 hasAuthorship W2894955366A5080326695 @default.
• W2894955366 hasAuthorship W2894955366A5082675564 @default.
• W2894955366 hasAuthorship W2894955366A5089160868 @default.
• W2894955366 hasAuthorship W2894955366A5089922398 @default.
• W2894955366 hasBestOaLocation W28949553661 @default.
• W2894955366 hasConcept C126322002 @default.

• next